IP Library Assignment 046254/0524
Patent Assignment
Reel/Frame 046254/0524

Security Interest

Recorded: 2018-07-02 Pages: 20
Assignors
ROMARK BIOSCIENCES S.À R.L. LLC
Executed: 2018-06-28
ROMARK LABORATORIES, L.C.
Executed: 2018-06-28
Assignee
U.S. BANK NATIONAL ASSOCIATION
ONE FEDERAL STREET, 3RD FLOOR, BOSTON, MASSACHUSETTS, 02110
Covered Properties (26)
Thiazolide Compounds for Treating Viral Infections
Inhibition of Protein Disulfide-Isomerase A3
Halogenated Benzamide Derivatives
Patent: 7,285,567 →
Application: 11/221,256 →
Publication: US 2006/0089396
Viral hepatitis treatment
Patent: 8,633,230 →
Application: 11/651,672 →
Publication: US 2007/0167504
Halogenated Benzamide Derivatives
Patent: 7,645,783 →
Application: 11/865,532 →
Publication: US 2008/0096941
Halogenated Benzamide Derivatives
Patent: 7,550,493 →
Application: 11/865,541 →
Publication: US 2008/0097106
Alkylsulfonyl-Substituted Thiazolide Compounds
Patent: 8,124,632 →
Application: 12/184,760 →
Publication: US 2009/0036467
Controlled Release Pharmaceutical Formulations of Nitazoxanide
Patent: 8,524,278 →
Application: 12/656,704 →
Publication: US 2010/0209505
Haloalkyl Heteroaryl Benzamide Compounds
Patent: 8,846,727 →
Application: 12/777,383 →
Publication: US 2010/0292274
Compounds and Methods for Treating Influenza
Patent: 9,023,877 →
Application: 12/821,571 →
Publication: US 2010/0330173
Alkylsulfinyl-Substituted Thiazolide Compounds
Patent: 8,772,502 →
Application: 13/284,242 →
Publication: US 2012/0108591
Alkylsulfonyl-Substituted Thiazolide Compounds
Patent: 8,895,752 →
Application: 13/353,686 →
Publication: US 2012/0122939
Controlled Release Pharmaceutical Formulations of Nitazoxanide
Patent: 9,351,937 →
Application: 13/954,184 →
Publication: US 2014/0065215
Viral Hepatitis Treatment
Patent: 9,107,913 →
Application: 14/137,280 →
Publication: US 2014/0112888
Haloalkyl Heteroaryl Benzamide Compounds
Patent: 9,126,992 →
Application: 14/451,637 →
Publication: US 2014/0341850
Compounds and Methods for Treating Influenza
Patent: 9,345,690 →
Application: 14/658,409 →
Publication: US 2015/0250768
Compounds and Methods for Treating Influenza
Patent: 9,820,975 →
Application: 15/133,534 →
Publication: US 2016/0228415
Controlled Release Pharmaceutical Formulations of Nitazoxanide
Patent: 9,827,227 →
Application: 15/141,921 →
Publication: US 2016/0243087
Haloalkyl Heteroaryl Benzamide Compounds
Patent: 46,724 →
Application: 15/156,580 →
Thiazolide Compounds for Treating Viral Infections
Application: 15/474,267 →
Publication: US 2017/0281603
Compositions and Methods of Treatment with Prodrugs of Tizoxanide, an Analogue or Salt Thereof
Application: 15/525,658 →
Publication: US 2017/0334868
Viral Hepatitis Treatment
Patent: 47,404 →
Application: 15/644,637 →
Controlled Release Pharmaceutical Formulations of Nitozoxanide
Application: 15/814,850 →
Publication: US 2018/0085353
Compounds and Methods for Treating Influenza
Application: 15/814,949 →
Publication: US 2018/0078533
Use of Thiazolide Compounds for the Prevention and Treatment of Viral Diseases, Cancer and Diseases Caused by Intracellular Infections
Application: 15/861,234 →
Publication: US 2018/0126722
Haloalkyl Heteroaryl Benzamide Compounds
Patent: 47,786 →
Application: 15/864,411 →
Related Assignments (23)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement Sep 26, 2006
From: ROMARK LABORATORIES, L.C.
To: MERRILL LYNCH CAPITAL, A DIVISION OF MERRILL LYNCH BUSINESS FINANCIAL SERVICES, INC.
Reel/Frame 018303/0163 →
Assignment of Assignor's Interest Oct 24, 2006
From: ROSSIGNOL, JEAN-FRANCOIS
To: ROMARK LABORATORIES, L.C.
Reel/Frame 018428/0233 →
Termination of Security Interest Mar 22, 2007
From: MERRILL LYNCH CAPITAL, A DIVISION OF MERRILL LYNCH BUSINESS FINANCIAL SERVICES, INC.
To: ROMARK LABORATORIES, L.C.
Reel/Frame 019047/0410 →
Notice of Grant of Security Interest Mar 23, 2007
From: ROMARK LABORATORIES, L.C.
To: LAMINAR DIRECT CAPITAL L.P., AS COLLATERAL AGENT
Reel/Frame 019055/0317 →
Assignment of Assignor's Interest Jan 14, 2008
From: ROSSIGNOL, JEAN FRANCOIS
To: ROMARK LABORATORIES L.C.
Reel/Frame 020358/0660 →
Assignment of Assignor's Interest Jan 14, 2008
From: ROSSIGNOL, JEAN FRANCOIS
To: ROMARK LABORATORIES L.C.
Reel/Frame 020358/0710 →
Assignment of Assignor's Interest Sep 5, 2008
From: ROSSIGNOL, JEAN-FRANCOIS
To: ROMARK LABORATORIES, L.C.
Reel/Frame 021487/0446 →
Assignment of Assignor's Interest Sep 15, 2008
From: ROSSIGNOL, JEAN-FRANCOIS; SEMPLE, J. EDWARD
To: ROMARK LABORATORIES L.C.
Reel/Frame 021530/0305 →
Notice of Grant of Security Interest in Patents Sep 28, 2009
From: ROMARK LABORATORIES, L.C.
To: LAMINAR DIRECT CAPITAL, L.L.C., AS COLLATERAL AGENT
Reel/Frame 023282/0880 →
Assignment of Assignor's Interest Feb 12, 2010
From: ROSSIGNOL, JEAN-FRANCOIS; AYERS, MARC
To: ROMARK LABORATORIES L.C.
Reel/Frame 023976/0831 →
Assignment of Assignor's Interest May 11, 2010
From: ROSSIGNOL, JEAN-FRANCOIS; SEMPLE, J. EDWARD
To: ROMARK LABORATORIES L.C.
Reel/Frame 024364/0392 →
Assignment of Assignor's Interest Jul 26, 2010
From: ROSSIGNOL, JEAN-FRANCOIS; SEMPLE, J. EDWARD
To: ROMARK LABORATORIES L.C.
Reel/Frame 024737/0670 →
Change of Name Jul 29, 2011
From: LAMINAR DIRECT CAPITAL L.P.
To: LAMINAR DIRECT CAPITAL, L.L.C.
Reel/Frame 026676/0247 →
Change of Name Jul 29, 2011
From: LAMINAR DIRECT CAPITAL L.P.
To: LAMINAR DIRECT CAPITAL, L.L.C. (FORMERLY KNOWN AS LAMINAR DIRECT CAPITAL L.P.)
Reel/Frame 026676/0386 →
Security Agreement Jul 29, 2011
From: ROMARK LABORATORIES, L.C.
To: PAUL CAPITAL FUND MANAGEMENT, L.L.C.
Reel/Frame 026676/0635 →
Release of Security Interest Jul 29, 2011
From: LAMINAR DIRECT CAPITAL, L.L.C. (FORMERLY KNOWN AS LAMINAR DIRECT CAPITAL L.P.)
To: ROMARK LABORATORIES, L.C.
Reel/Frame 026676/0576 →
Release of Security Interest Jul 29, 2011
From: LAMINAR DIRECT CAPITAL, L.L.C. (SUCCESSOR IN INTEREST TO LAMINAR DIRECT CAPITAL L.P.)
To: ROMARK LABORATORIES, L.C.
Reel/Frame 026676/0482 →
Assignment of Assignor's Interest Jan 10, 2012
From: SEMPLE, J. EDWARD; ROSSIGNOL, JEAN-FRANCOIS
To: ROMARK LABORATORIES, L.C.
Reel/Frame 027505/0508 →
Release of Security Interest Sep 3, 2013
From: PAUL CAPITAL FUND MANAGEMENT, L.L.C.
To: ROMARK LABORATORIES, L.C.
Reel/Frame 031159/0636 →
Security Agreement Sep 4, 2013
From: ROMARK LABORATORIES, L.C.; ROMARK MANUFACTURING, LLC; LAPICOR, N.V.
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 031156/0923 →
Release of Security Interest Mar 6, 2015
From: U.S. BANK NATIONAL ASSOCIATION
To: ROMARK LABORATORIES, L.C.; ROMARK MANUFACTURING, LLC; LAPICOR, N.V.
Reel/Frame 035108/0474 →
Security Interest Dec 22, 2017
From: ROMARK BIOSCIENCES S.À R.L. LLC; ROMARK LABORATORIES, L.C.
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 044472/0001 →
Security Interest Nov 16, 2019
From: ROMARK BIOSCIENCES S.À R.L. LLC; ROMARK LABORATORIES, L.C.
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 051030/0613 →